Sequel’s attorneys work collaboratively with pharmaceutical, biotechnology, and medical device manufacturers to maximize their development and commercialization opportunities and advance their corporate-responsibility objectives, including health data protection.
On a day-to-day basis, these activities often translate into meticulous research into federal regulations, guidance, and notices; analyses of potential impacts on patients, providers, payers, and the public; and the development of recommendations to advance the interests of clients, patients, and the public.